FDA on July 23rd issued a warning letter to CBD-producer Curaleaf, Inc, citing unsubstantiated health claims for its products. Here are 10 of the claims your patients are reading.
One of more than a dozen statements found on product Webpages, online stores, and
social media accounts managed by Curaleaf, Inc, Wakefield, Mass. The company is one of the most recent to be notified by the US FDA of unsubstantiated health claims made for its CBD-based products.
“The top five research backed benefits of CBD include: 1) neuro[de]generative disease 2) depression and anxiety treatment 3) pain treatment 4) aids in the treatment of cancer and related symptoms to cancer . . ..”
“CBD has also been shown to be effective in treating Parkinson’s disease.” “CBD has been linked to the effective treatment of Alzheimer’s disease ….”
“A 2018 study showed that CBD offers quick relief of depression and anxiety symptoms and that the residual effects can last up to seven days.”
Some of the most researched and well-supported hemp oil uses include …Anxiety, depression, post-traumatic stress disorders, and even schizophrenia …. Chronic pain from fibromyalgia, slipped spinal discs . . . Eating disorders and addiction . . ..”
“The Benefits of CBD Oil for ADHD . . . It can also help to restore focus and ability to concentrate on specific tasks, as well as reduce impulsivity.”
“CBD can also be used in conjunction with opioid medications, and a number of studies have demonstrated that CBD can in fact reduce the severity of opioid-related withdrawal and lessen the buildup of tolerance.”
“Heart disease is one of the leading causes of death in the United States each year, and CBD does a number of things to deter it. The two most important of these are the ability to lower blood pressure, and the ability to promote good cholesterol and lower bad cholesterol.”
“[V]ets will prescribe puppy Xanax to pet owners which can help in certain instances but is not necessarily a desirable medication to give your dog continually. Whereas CBD oil is natural and offers similar results without the use of chemicals.”
On Tuesday, July 23, 2019, the FDA issued a warning letter to Curaleaf, Inc, of Wakefield, Mass, for unsubstantiated health claims made about its wide range of cannabidiol (CBD)-based products. Among the company's many therapeutic claims are that its CBD oil treats cancer, opioid withdrawal, Alzheimer disease, heart disease, and pet pain and anxiety. The products marketed include tinctures, lotions, pain patches, and disposable vape pens. Click through the slides below for 10 examples of the specific claims for CBD oil made by Curaleaf. This is what your patiets are reading.Â